PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance

Journal of Clinical Investigation

Volumn 105, Issue 9, 2000, Pages 1307-1315

  Jamen, Françoise ^a   Persson, Kristin ^b   Bertrand, Gyslaine ^a   Rodriguez Henche, Nieves ^a,c   Puech, Raymond ^a   Bockaert, Joël ^d   Ahrén, Bo ^b   Brabet, Philippe ^a  

^a CNRS   (France)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FOOD INTAKE; GENE TARGETING; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESPONSE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

EID: 0034063578     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9387     Document Type: Article

References (39)

1. Henquin, J.C. 1994. Cell biology of insulin secretion. In Joslin's diabetes mellitus. 13th edition. C.R. Kahn, and G.C. Weir, editors. Lea & Febiger, Philadelphia, Pennsylvania, USA. 56-80.
2. Schebalin, M., Said, S.I., and Makhlouf, G.M. 1977. Stimulation of insulin and glucagon secretion by vasoactive intestinal peptide. Am. J. Physiol. 232:E197-E200.
3. Pipeleers, D., in't Veld, P.I., Maes, E., and Van De Winkel, M. 1982. Glucose-induced insulin release depends on functional cooperation between islet cells. Proc. Natl. Acad. Sci. USA. 79:7322-7325.
4. Ahren, B. 1998. Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes. Bioessays. 20:642-651.
5. Miyata, A., et al. 1989. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164:567-574.
6. Kawai, K., et al. 1992. Pituitary adenylate cyclase activating polypeptide stimulates insulin release from the isolated perfused rat pancreas. Life Sci. 50:257-261.
7. Yokota, C., et al. 1993. Stimulatory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on insulin and glucagon release from the isolated perfused rat pancreas. Acta Endocrinol. (Copenh.) 129:473-479.
8. Bertrand, G., Puech, R., Maisonnasse, Y., Bockaert, J., and Loubatieres-Mariani, M.M. 1996. Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat. Br. J. Pharmacol. 117:764-770.
9. Yada, T., et al. 1994. Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J. Biol. Chem. 269:1290-1293.
10. Filipsson, K., Sundler, F., and Ahren, B. 1999. PACAP is an islet neuropeptide which contributes to glucose-stimulated insulin secretion. Biochem. Biophys. Res. Commun. 256:664-667.
11. Filipsson, K., Pacini, G., Scheurink, A.J., and Ahren, B. 1998. PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice. Am. J. Physiol. 274:E834-E842.
12. Filipsson, K., Tornoe, K., Holst, J., and Ahren, B. 1997. Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans. J. Clin. Endocrinol. Metab. 82:3093-3098.
13. Miyata, A., et al. 1990. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem. Biophys. Res. Commun. 170:643-648.
14. Filipsson, K., Sundler, F., Hannibal, J., and Ahren, B. 1998. PACAP and PACAP receptors in insulin producing tissues: localization and effects. Regul. Pept. 74:167-175.
15. Fridolf, T., Sundler, F., and Ahren, B. 1992. Pituitary adenylate cyclase-activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse. Cell Tissue Res. 269:275-279.
16. Spengler, D., et al. 1993. Differential signal transduction by five splice variants of the PACAP receptor. Nature. 365:170-175.
17. Arimura, A., and Shioda, S. 1995. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front. Neuroendocrinol. 16:53-88.
18. Harmar, A.J., et al. 1998. International Union of Pharmacology, XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 50:265-270.
19. Straub, S.G., and Sharp, G.W. 1996. A wortmannin-sensitive signal transduction pathway is involved in the stimulation of insulin release by vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide. J. Biol. Chem. 271:1660-1668.
20. Yada, T., et al. 1997. Pituitary adenylate cyclase-activating polypeptide (PACAP) is an islet substance serving as an intra-islet amplifier of glucose-induced insulin secretion in rats. J. Physiol. (Lond.) 505:319-328.
21. Pantaloni, C., et al. 1996. Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation. J. Biol. Chem. 271:22146-22151.
22. Soriano, P., Montgomery, C., Geske, R., and Bradley, A. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell. 64:693-702.
23. Mansour, S.L., Thomas, K.R., and Capecchi, M.R. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature. 336:348-352.
24. Shivers, B.D., Gorcs, T.J., Gottschall, P.E., and Arimura, A. 1991. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions. Endocrinology. 128:3055-3065.
25. Lafon-Cazal, M., et al. 1999. mGluR7-like metabotropic glutamate receptors inhibit NMDA-mediated excitotoxicity in cultured mouse cerebellar granule neurons. Eur. J. Neurosci. 11:663-672.
26. Salomon, Y., Londos, C., and Rodbell, M. 1974. A highly sensitive adenylate cyclase assay. Anal. Biochem. 58:541-548.
27. Bertrand, G., Chapal, J., and Loubatieres-Mariani, M.M. 1986. Potentiating synergism between adenosine diphosphate or triphosphate and acetylcholine on insulin secretion. Am. J. Physiol. 251:E416-E421.
28. Masuo, Y., Ohtaki, T., Masuda, Y., Tsuda, M., and Fujino, M. 1992. Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections. Brain Res. 575:113-123.
29. Carlsson, P.O., Ostenson, C.G., Efendic, S., Langel, U., and Jansson, L. 1996. Pituitary adenylate cyclase activating polypeptide (PACAP) redistributes the blood within the pancreas of anesthetized rats. Regul. Pept. 63:123-128.
30. Schuit, F.C. 1996. Factors determining the glucose sensitivity and glucose responsiveness of pancreatic beta cells. Horm. Res. 46:99-106.
31. Klinteberg, K.A., Karlsson, S., and Ahren, B. 1996. Signaling mechanisms underlying the insulinotropic effect of pituitary adenylate cyclase-activating polypeptide in HIT-T15 cells. Endocrinology. 137:2791-2798.
32. Davalli, A.M., et al. 1999. Insulin and intracellular calcium responsiveness to glucagon-like peptide-1 and pituitary adenylate cyclase-activating peptide by dispersed adult porcine islet cells. Transplantation. 67:174-176.
33. Wei, Y., and Mojsov, S. 1996. Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: implications for their role in human physiology. J. Neuroendocrinol. 8:811-817.
34. Nakata, M., Shioda, S., Oka, Y., Maruyama, I., and Yada, T. 1999. Insulinotropin PACAP potentiates insulin-stimulated glucose uptake in 3T3 L1 cells. Peptides. 20:943-948.
35. Sekiguchi, Y., Kasai, K., Hasegawa, K., Suzuki, Y., and Shimoda, S. 1994. Glycogenolytic activity of pituitary adenylate cyclase activating polypeptide (PACAP) in vivo and in vitro. Life Sci. 55:1219-1228.
36. Yokota, C., Kawai, K., Ohashi, S., Watanabe, Y., and Yamashita, K. 1995. PACAP stimulates glucose output from the perfused rat liver. Peptides. 16:55-60.
37. Filipsson, K., Holst, J.J., and Ahrén, B. 1999. PACAP contributes to insulin secretion induced by gastric glucose gavage m mice. Diabetologia. 42(Suppl. 1):A40. (Abstr.)
38. Ahren, H. 1999. Regulation of insulin secretion by nerves and neuropeptides. Ann. Acad. Med. Singapore. 28:99-104.
39. Tornoe, K., Hannibal, J., Fahrenkrug, J., and Holst, J.J. 1997. PACAP-(1-38) as neurotransmitter in pig pancreas: receptor activation revealed by the antagonist PACAP-(6-38). Am. J. Physiol. 273:G436-G446.